Feature | February 22, 2013| Dave Fornell

FDA Approves Use of Common Abbott Devices to Treat for Coronary CTOs

Additional indications allow its everyday guidewires and balloons to be used in chronic total occlusions (CTOs)

balloon, CTO

Abbott's Mini-Trek balloon dilatation catheter.

guidewire, CTO

Abbott'e HT Pilot guidewire.

February 22, 2013 — Physicians have new tools for treating coronary chronic total occlusions (CTOs) after Abbott received U.S. Food and Drug Administration (FDA) approval this week for guidewires and balloon dilation catheters for treatment of CTOs. Abbott is the only company with FDA approvals of its everyday products for treatment of CTOs.

The FDA approval is for Abbott's HT Progress and HT Pilot guidewires and Mini-Trek balloon dilatation catheter products.

Treatment of CTOs, a 100 percent blockage in the artery, continues to be a controversial topic among cardiac specialists, though estimates indicate that 15 to 20 percent of patients undergoing coronary angiography have a CTO. While some physicians believe they are benign, others believe that CTOs are a slow, silent killer. In addition, treating CTOs with minimally invasive methods is not easy. Up until now, only a handful of specialty CTO products were approved to tackle these lesions.

While the recommended treatment for CTOs varies widely among doctors, many say coronary CTOs offer a potential growth area for patient volume in cath labs. Clinical evidence supports the treatment of CTOs if good procedural outcomes can be obtained. Patients with CTOs can experience significant improvements in quality of life if blood flow is restored to the vessel.

Clearly navigating CTOs can be difficult under 2-D angiography, which only shows a lumengram in the parts of the vessel that are not blocked. The controversy over treating CTOs often involves the guesswork involved when attempting to push wires through the occlusion without piercing the wall of the artery. However, recent advances in 3-D rotational angiography and fusion imaging with these images or computed tomography (CT) or magnetic resonance imaging (MRI) 3-D vessel reconstructions overlaid on live fluoroscopy are expected to greatly aid these types of procedures.

For more information: www.abbottvascular.com

 

 

 

 

Related Content

Million Hearts Cardiovascular Disease Risk Reduction Model, CMS, reduce heart attacks and strokes, participants
News | Patient Engagement| July 22, 2016
July 22, 2016 — The Centers for Medicare & Medicaid Services (CMS) recently announced 516 awardees in 47 states,
heart failure, after first heart attack, cancer risk, JACC study
News | Cardiac Diagnostics| July 21, 2016
People who develop heart failure after their first heart attack have a greater risk of developing cancer when compared...
Absorb, bioresorbable stent, BVS
Feature | Stents Bioresorbable| July 21, 2016 | Alphonse Ambrosia, D.O.
Some have labeled bioresorbable scaffolds (BRS), also known as bioresorbable stents, as the fourth revolution of inte
Sponsored Content | Videos | Inventory Management| July 19, 2016
You have bigger priorities than managing inventory.
Abbott Absorb bioresorbable stent, dissolving BVS, first West Coast implant, Good Samaritan Hospital Los Angeles
News | Stents Bioresorbable| July 19, 2016
Good Samaritan Hospital, Los Angeles, is the first hospital on the West Coast to offer patients with coronary artery...
Medtronic, In.Pact Admiral drug coated balloon, DCB, FDA approval, 150 mm length
Technology | Drug-Eluting Balloons| July 18, 2016
Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for the IN.PACT Admiral drug-coated balloon...
3-D OCT

A 3-D OCT rendering of a stented vessel segment created on St. Jude Medical's Ilumien Optis OCT system. 

Feature | Angiography| July 15, 2016 | Dave Fornell
While angiographic X-ray fluoroscopy systems are the workhorse for transcatheter cardiovascular interventional proced
VentureMed Group, Flex Scoring Catheter, FDA approval, peripheral arterial disease, PAD, endovascular treatment
Technology | Catheters| July 13, 2016
July 13, 2016 — VentureMed Group Ltd., specializing in devices for the endovascular treatment of...
radial access, inserting stents, JACC Cardiovascular Interventions study
News | Radial Access| July 13, 2016
A new study in JACC: Cardiovascular Interventions supports access through the wrist, or radial access, as the default...
Toshiba, Infinix, 4DCT, CT-Angio

Toshiba’s Infinix 4DCT combines an Infinix Elite angiography system an Aquilion One Vision edition CT system. It allows clinicians to plan, treat and verify in a single clinical setting. The CT system is capable of capturing an entire organ in one rotation with 640 slices and 16 cm of anatomical coverage. 

Feature | Angiography| July 12, 2016 | Dave Fornell
Angiographic imaging system vendors have developed new technologies to address emerging cath lab trends, including th
Overlay Init